Wednesday, February 10, 2010, 7:59pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Javelin Pharmaceuticals, Inc. (JAV)

At 5:00AM SGT: 1.17 USD   0.00 (0.00%)  
 MORE ON JAV 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 JAVELIN PHARMACEUTIC (AMEX:JAV) Delayed quote dataEdit
Last Trade:1.17 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:1.17
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:2.00
Day's Range:N/A - N/A
52wk Range:1.01 - 2.28
Volume:0
Avg Vol (3m):695,286
Market Cap:74.72M
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add JAV to Portfolio   Download Data

 HEADLINES 
•FDA takes up Javelin drug for review
at bizjournals.com (Wed, Feb 3)
•JAVELIN PHARMACEUTICALS, INC Files SEC form 8-K, Other Events
EDGAR Online (Wed, Feb 3)
•FDA Accepts Javelin Pharmaceuticals' Dyloject New Drug Application for Formal Review
Business Wire (Tue, Feb 2)
•Javelin merger hit by class-action flurry
at bizjournals.com (Tue, Jan 12)
•JAVELIN PHARMACEUTICALS, INC Files SEC form 8-K, Other Events
EDGAR Online (Sat, Jan 9)
•[$$] 13D Filings
at Barrons.com (Sat, Jan 2)
•Javelin CFO Tulipano inks retention plan
at bizjournals.com (Fri, Dec 25)
•JAVELIN PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
EDGAR Online (Thu, Dec 24)
•Finkelstein Thompson LLP Announces Investigation of Javelin Pharmaceuticals, Inc.
Business Wire (Wed, Dec 23)
•Javelin shares fall following analyst downgrade
AP (Tue, Dec 22)
More Headlines for JAV...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.58
EPS Est (in 2 years) (Dec-10) :-0.37
Avg Rec (current)*:2.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices